Laman UtamaDTIL • NASDAQ
add
Precision BioSciences Inc
$5.74
Selepas Waktu Dagangan:(1.22%)-0.070
$5.67
Tutup: 13 Jan, 7:58:07 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$5.70
Julat hari
$5.10 - $6.00
Julat tahun
$3.61 - $19.43
Permodalan pasaran
45.30J USD
Bilangan Purata
800.37K
Nisbah P/E
109.54
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 576.00K | -95.61% |
Perbelanjaan pengendalian | 21.85J | -14.25% |
Pendapatan bersih | -16.42J | -103.30% |
Margin untung bersih | -2.85K | -4,530.66% |
Pendapatan bagi setiap syer | -2.25 | — |
EBITDA | -20.56J | -91.38% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 101.20J | -17.20% |
Jumlah aset | 153.26J | -6.75% |
Jumlah liabiliti | 88.39J | -34.66% |
Jumlah ekuiti | 64.87J | — |
Syer tertunggak | 7.67J | — |
Harga kepada buku | 0.66 | — |
Pulangan pada aset | -33.34% | — |
Pulangan pada modal | -53.00% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -16.42J | -103.30% |
Tunai daripada operasi | -5.91J | 74.40% |
Tunai daripada pelaburan | -64.00K | -100.85% |
Tunai daripada pembiayaan | 3.73J | 11,079.41% |
Perubahan bersih dalam tunai | -2.24J | 85.59% |
Aliran tunai bebas | 3.30J | 115.16% |
Perihal
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
Diasaskan
2006
Tapak web
Pekerja
108
